Eight Functional Polymorphisms in the Estrogen Receptor 1 Gene and Endometrial Cancer Risk: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Zhou, Xin ^a   Gu, Yang ^a   Wang, Ding ning ^a   Ni, Sha ^a   Yan, Jun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; ESTROGEN RECEPTOR ALPHA; GUANOSINE; THYMINE;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CODON; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; ESTROGEN RECEPTOR 1 GENE; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

CONTINENTAL POPULATION GROUPS; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84876008763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060851     Document Type: Article

References (30)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, et al. (2005) Endometrial cancer. Lancet 366: 491-505.
3. Long J, Zheng W, Xiang YB, Lose F, Thompson D, et al. (2012) Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiol Biomarkers Prev 21: 980-987.
4. Olson SH, Bandera EV, Orlow I, (2007) Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 165: 235-245.
5. McKean-Cowdin R, Feigelson HS, Pike MC, Coetzee GA, Kolonel LN, et al. (2001) Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype. Cancer Res 61: 848-849.
6. Kataoka N, Cai Q, Xu WH, Xiang YB, Cai H, et al. (2007) Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene. Cancer 109: 1296-1302.
7. Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, et al. (2010) Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis 31: 827-833.
8. Lundin E, Wirgin I, Lukanova A, Afanasyeva Y, Krogh V, et al. (2012) Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol 36: 445-452.
9. Lluis-Ganella C, Lucas G, Subirana I, Escurriol V, Tomas M, et al. (2009) Qualitative assessment of previous evidence and an updated meta-analysis confirms lack of association between the ESR1 rs2234693 (PvuII) variant and coronary heart disease in men and women. Atherosclerosis 207: 480-486.
10. Tsezou A, Tzetis M, Gennatas C, Giannatou E, Pampanos A, et al. (2008) Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer. Breast 17: 159-166.
11. Jongen V, Briet J, de Jong R, ten Hoor K, Boezen M, et al. (2009) Expression of estrogen receptor-alpha and-beta and progesterone receptor-A and-B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol 112: 537-542.
12. Wang Y, Cui M, Zheng L, (2012) Genetic polymorphisms in the estrogen receptor-alpha gene and the risk of endometrial cancer: a meta-analysis. Acta Obstet Gynecol Scand 91: 911-916.
13. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M, (2011) Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1: e000048.
14. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
15. Zintzaras E, Ioannidis JP, (2005) Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28: 123-137.
16. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
17. Weiderpass E, Persson I, Melhus H, Wedren S, Kindmark A, et al. (2000) Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 21: 623-627.
18. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R, (2002) Polymorphisms of estrogen receptor alpha gene in endometrial cancer. Biochem Biophys Res Commun 297: 558-564.
19. Iwamoto I, Fujino T, Douchi T, Nagata Y, (2003) Association of estrogen receptor alpha and beta3-adrenergic receptor polymorphisms with endometrial cancer. Obstet Gynecol 102: 506-511.
20. Shan D, Ben JH, Guo YY, (2003) [Study on the relationship between polymorphism of the estrogen receptor gene and endometrial carcinoma]. Chin J Clin Obstet Gynecol 4: 201-205.
21. Yang XS, Liu J, Zhong YH, Zhang X, Wang Y, (2007) The relationship between single nucleotide polymorphisms in estrogenmetabolizing genes CYP1A1,CYP17,COMT and estrogen receptor alpha and the risk of endometrial adenocarcinoma among the Chinese women. Prog Obstet Gynecol 16: 76-80.
22. Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, et al. (2008) Estrogen receptor alpha gene polymorphism and endometrial cancer risk-a case-control study. BMC Cancer 8: 322.
23. Sobczuk A, Smolarz B, Romanowicz-Makowska H, Pertynski T, (2009) Estrogen receptor alpha (ER-alpha) gene polymorphism in patients from the Lodz region of Poland with sporadic endometrial cancer. Eur J Gynaecol Oncol 30: 431-434.
24. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, et al. (2010) Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol 34: 328-337.
25. Sliwinski T, Sitarek P, Stetkiewicz T, Sobczuk A, Blasiak J, (2010) Polymorphism of the ERalpha and CYP1B1 genes in endometrial cancer in a Polish subpopulation. J Obstet Gynaecol Res 36: 311-317.
26. Healey CS, Ahmed S, O'Mara TA, Ferguson K, Lambrechts D, et al. (2011) Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenesis 32: 1862-1866.
27. Li G, Xiang YB, Courtney R, Cheng JR, Huang B, et al. (2011) Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women. Chin J Cancer 30: 138-143.
28. Koukouras D, Marioli DJ, Papadopoulos K, Adonakis GL, Armeni AK, et al. (2012) Association of estrogen receptor alpha (ERalpha) gene polymorphisms with endometrial thickness and lipid profile in women with breast cancer treated with aromatase inhibitors. Gynecol Endocrinol 28: 859-862.
29. Li N, Dong J, Hu Z, Shen H, Dai M, (2010) Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121: 177-184.
30. Safarinejad MR, Safarinejad S, Shafiei N, (2012) Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men. Mol Carcinog 51 (Suppl 1): E104-117.